Daily Equity Reports 14 Feb 2019

CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647
DAILY EQUITY REPORT
14TH
FEBRUARY 2019
Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of
future performance.

INDIAN MARKET
CLOSE PREVIOUS
NIFTY
CLOSE PREVIOUS
NIKKEI
2201.48 2190.47
SECTORIAL INDICES
CLOSE CHANGE (%)
CNX 100
S&P CNX 500
8887.90
4476.65
CNX 200 5608.95
BANK NIFTY
TOP GAINERS
CLOSE CHANGE (%)
4.82
3.61
UPL 2.30
2.21
TOP LOSERS
Daily Equity Report
INDIAN FACE
!
INDIAN EQUITY BENCHMARK - Benchmark indices erased
all its intraday gains and ended in red on the back of last
hour selling pressure. The Sensex was down 119.51 points
at 36034.11, while Nifty was down 37.70 points at 10793.70.
About 968 shares have advanced, 1544 shares declined, and
128 shares are unchanged.
GLOBAL FACE
!
Asian Market - Asian markets closed sharply higher today
with shares in China leading the region. The Shanghai
Composite is up 1.84% while Japan's Nikkei 225 is up 1.34%
and Hong Kong's Hang Seng is up 1.15%.
!
U.S. Market – North and South American markets finished mixed as
of the most recent closing prices. The Bovespa
gained 1.86% and the S&P 500 rose 1.29%. The IPC lost
0.40%.
!
European markets - European markets are higher today
with shares in London leading the region. The FTSE 100 is up
0.47% while France's CAC 40 is up 0.24% and Germany's DAX
is up 0.08%.
CLOSE CHANGE (%)
-4.82
IOC -3.90
-3.87
-3.09
future performance.

Daily Equity Report
MARKET MOVERS UPSIDE
SCRIPT CLOSE
(%)
ADANIPORT 4.82
0.96
HDFC 0.82
0.55
MARKET MOVERS DOWNSIDE
CLOSE
(%)
-4.82
-3.05
ONGC -2.98
GAIL -2.82
NET BUY NET
(CR.) SELL (CR)
4020.15
DII 2441.11
NSE TOTALS
ADVANCE
S
NIFTY
BANK NIFTY
NIFTY SPOT
TREND STRATEGY
BEARISH
PIVOT POINTS
S3 S2 R1 R2 R3
10580 10699 10746 10819 10866 10938 11058
S1-10746 R1-10866
S2-10699 R2-10938
STRATEGY
BEARISH SELL ON RISE
PIVOT POINTS
S1 P R1 R2 R3
26413 26736 26847 27060 27171 27384 27708
RESISTANCE
BANK NIFTY
future performance.

Daily Equity Report
MARKET TALKS
! CG power crashes ~30% post Q3
!
Zydus gets final approval from USFDA
results for Triamterene
Shares of CG Power crashed ~30% in intraday trade on Hydrochlorothiazide Capsules USP
Wednesday. Shares touched a 52-week low of Rs26.65 Zydus Cadila has received the final approval from the
after the company reported a net loss of Rs150cr for USFDA to market Triamterene and Hydrochlorothiazide
Q3FY19 including a onetime loss of Rs116.6cr, as against a Capsules USP (US RLD -DYAZIDE), 37.5mg/25mg. It will
loss of Rs28.2cr in Q3FY18. The adjusted loss was be manufactured at the group's formulations
Rs33.6Cr as against adjusted loss of Rs25.6Cr in the same manufacturing facility at Ahmedabad. The
quarter last year. EBITDA rose by 14% and was pegged at dose combination of Triamterene and
Rs148.5cr, while EBITDA margin was at 8.6%. CG Power Hydrochlorothiazide is indicated for the treatment of
And Industrial Solutions Limited, formerly Crompton hypertension or edema in patients who have developed
Greaves Limited, is engaged in the business of power hypokalemia (low serum on
transformers and reactors, low tension motors and Hydrochlorothiazide alone. It is also indicated for those
switchgears. patients who require a thiazide diuretic and in whom the
! Bosch stock slips 4% post Q3FY19 development of hypokalemia cannot be risked. This
numbers medication may be used alone or as an adjunct to other
Shares of Bosch Ltd slipped ~4% despite reporting a
19.3% increase in standalone PAT for the third quarter
ended December 31, 2018. The company standalone PAT
rose to Rs335cr in Q3FY19 vs. Rs281cr in Q3FY18. The
company reported total revenue from operations at
Rs9,509cr, an increase of 11.4% over the same period last
year. "The result of this quarter has to be viewed in the
context of particularly weak market conditions in the
overall automotive sector. Bosch Ltd has always been
committed to delivering best-in-class automotive
solutions.
!
Bata India gains 5% post strong Q3FY19 results
HEG Shares of Bata India gained 5% in intraday trade on
Wednesday after the company posted a 51% rise in net profits in
Q3FY19. Bata India Ltds revenue for Q3FY19 came in at Rs779cr,
up 15.5% yoy and 15.7% qoq. EBITDA for the quarter came in at
Rs163.63cr, up 46.8% yoy and 87.3% qoq. The company's
EBITDA margin expanded 447bps yoy and 804bps qoq to 21%.
future performance.

Daily Equity Report
NAME OF THE STOCK : HEXAWARE
DATE : 14/02/2019
SEGMENT : CASH
CHART TYPE : Candlestick
EXCHANGE : NSE
TECHNICAL INDICATORS USED : VOLUME.MACD,RSI.
CHART
INVESTMENT ADVICE:
CALL CS CALL:- BUY HEXAWARE IN CASH NR CMP 367-368 TGT 380 SL 357
RATIONALE FOR ARRIVING INVESTMENT ADVICE :
TECHNICAL VIEW : THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY
WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF TREND REVERSAL IS THERE.
OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL.
future performance.

DISCLAIMER
The information and views in this report & all the service we provide are believed to be reliable, but
we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the
product/s that suits them the most. Sincere efforts have been made to present the right investment
perspective. The information contained herein is based on analysis and up on sources that we consider
reliable. This material is for personal information and based upon it & takes no responsibility. The
information given herein should be treated as only factor, while making investment decision. The
report does not provide individually tailor-made investment advice. My research recommends that
investors independently evaluate particular investments and strategies, and encourages investors to
seek the advice of a financial adviser. Capitalstars shall not be responsible for any transaction
conducted based on the information given in this report, which is in violation of rules and regulations
of regulators. The price projections shown are not necessarily indicative of future price performance.
The information herein, together with all estimates and forecasts, can change without notice. It is
understood that anyone who is browsing through the site has done so at his free will and does not read
any views expressed as a recommendation for which either the site or its owners or anyone can be
held responsible for. Investment & Trading in Securities Markets are always subjected to market risk.
Capitalstars Financial Research Private Ltd., Reserves all Rights.
INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK.
future performance.

CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair
and accurate trading and investment calls in share and commodity market. we specialize in thorough
fundamental and technical research analysis in equity and commodity market to provide best equity and
commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and
commodity tips in MCX and NCDEX.
Get our more services:-
Intraday stock tips
Financial advisory company
Share market company
Stock Tips
* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future
performance.
* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

BRANCH OFFICE
Capitalstars Financial Research Private Limited
PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME
NO.54,VIJAYNAGAR INDORE
REGISTERED OFFICE
PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE
Email:-backoffice@capiltalstars.in
Contact us :- 9977499927, 9039012727
Report Is Checked by Investment Advisor:
future performance.

Daily Equity Reports 14 Feb 2019

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Similar to Daily Equity Reports 14 Feb 2019

Similar to Daily Equity Reports 14 Feb 2019 (20)

More from Myra Cheng

More from Myra Cheng (20)

Recently uploaded

Recently uploaded (20)

Daily Equity Reports 14 Feb 2019